Belite Bio, INC 6-K Filing
Ticker: BLTE · Form: 6-K · Filed: Mar 31, 2026 · CIK: 0001889109
| Field | Detail |
|---|---|
| Company | Belite Bio, INC (BLTE) |
| Form Type | 6-K |
| Filed Date | Mar 31, 2026 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Belite Bio, INC (ticker: BLTE) to the SEC on Mar 31, 2026.
How long is this filing?
Belite Bio, INC's 6-K filing is 1 pages with approximately 255 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2026-03-31 08:01:39
Filing Documents
- tm261133d2_6k.htm (6-K) — 9KB
- tm261133d2_ex99-1.htm (EX-99.1) — 5KB
- tm261133d2_ex99-1img001.jpg (GRAPHIC) — 3KB
- 0001104659-26-037376.txt ( ) — 19KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15b-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-41359 Belite Bio, Inc (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant´s name into English) 12750 High Bluff Drive Suite 475, San Diego, CA 92130 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F On March 31, 2026, Belite Bio, Inc issued a press release entitled “Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website”. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This Report on Form 6-K shall be deemed to be incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933, and shall be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit 99.1 — Press Release SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Belite Bio, Inc By: /s/ Yu-Hsin Lin Name: Yu-Hsin Lin Title: Chief Executive Officer and Chairman Date: March 31, 2026